Hospital Pharmacist's Letter | Trusted CE & Recommendations

December 2024 Issue

Prepare to Give More Adults a Pneumococcal Vaccine

We’re getting lots of questions about pneumococcal vaccines for adults...

Resources

Chart: Comparison of Pneumococcal Vaccines
Algorithm: Pneumococcal Vaccination in Adults

Educate About the Medicare Prescription Payment Plan

Questions are swirling about the new Medicare Prescription Payment Plan (MPPP)...

Tackle Ongoing GLP-1 Agonist Questions

Questions continue to pour in about GLP-1 agonists (semaglutide, etc)...

Don’t Rush to Aprocitentan for Resistant Hypertension

Aprocitentan (Tryvio) will be the first dual endothelin antagonist approved for resistant hypertension...

GO TO FULL ISSUE

CE & Training

INTERACTIVE SELF STUDY CE: HIV PrEP and PEP

CE-IN-THE-LETTER: Hospital Pharmacist's Letter December 2024

LIVE CE: Pharmacy Essential Updates December 2024

PODCAST CE: Medication Talk - Natural Medicines Highlights

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GO TO ALL CLINICAL RESOURCES >

Welcome to Your Hospital Pharmacist's Letter

We value you and hope you take advantage of all the features of your subscription. For example, ask medication therapy questions and provide answers alongside your colleagues in the Forum.

Developing Your Pharmacy Career

Hospital Pharmacist's Letter is one of many CE and training solutions from TRC Healthcare. We support pharmacists like you at all stages of their career. Learn more about our:

Group Purchases & Pricing

Hospital Pharmacist’s Letter is eligible for bulk discounts. Easily manage pharmacy-specific competency and compliance training. Bundle with other products for significant savings. Request information